×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: Actual Requirements of Cartagena Type Use 1 for Medical Institutions from Pharmaceutical Point of View [English]
Session Chair(s)
Daisaku Sato, PhD, MPharm, RPh
Director, Compliance & Narcotics Division
Ministry of Health, Labour and Welfare, Japan
Sumimasa Nagai, MD, PhD
Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan
Speaker(s)
Masafumi Onodera, MD, PhD
National Center for Child Health and Development, Japan
Director, Center of Gene Cell Therapy Promotion,
Have an account?